Namibia - English - Namibia Medicines Regulatory Council

jansen pharmaceuticals - estradiol, estradiol hemihydrate , norethisterone acetate - tds - transdermal delivery system, estradiol, estradiol hemihydrate & norethisterone acetate

Israel - English - Ministry of Health

truemed ltd. - estradiol as hemihydrate; norethisterone acetate - patches - estradiol as hemihydrate 3.2 mg; norethisterone acetate 11.2 mg - estradiol, combinations - estradiol, combinations - hormone replacement therapy for the relief of menopausal symptoms.

Israel - English - Ministry of Health

bayer israel ltd - norethisterone acetate - tablets - norethisterone acetate 5 mg - norethisterone - norethisterone - oral progestron for: dysfunctional bleeding, primary and secondary amenorrhea, premenstrual syndrome, timing of mensturation and endometriosis.

Ireland - English - HPRA (Health Products Regulatory Authority)

novo nordisk a/s - estradiol; norethisterone acetate - film-coated tablet - 2 mg/1 milligram(s) - progestogens and estrogens, fixed combinations; norethisterone and estrogen

Australia - English - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - nomegestrol acetate, quantity: 2.5 mg; estradiol hemihydrate, quantity: 1.55 mg (equivalent: estradiol, qty 1.5 mg) - tablet, film coated - excipient ingredients: crospovidone; magnesium stearate; microcrystalline cellulose; purified talc; lactose monohydrate; colloidal anhydrous silica; titanium dioxide; iron oxide yellow; polyvinyl alcohol; macrogol 3350; iron oxide black - oral contraception.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - estradiol, quantity: 0.78 mg (equivalent: estradiol, qty 50 microgram/24 h; equivalent: estradiol hemihydrate, qty 0.806 mg) - drug delivery system, transdermal - excipient ingredients: povidone; dipropylene glycol; oleyl alcohol; ethyl acetate; toluene; acrylates/va copolymer; polyethylene terephthalate; polyvinylidene flouride; ethylene/vinyl acetate copolymer; 1,1-dichloroethylene, chloroethylene polymer; polyethylene; sodium carbonate; simethicone; dimeticone; xylene; cyclomethicone - for the short-term treatment of symptoms of oestrogen deficiency in menopausal women who have an intact uterus. combination hrt should not be used in hysterectomised women because it is not needed in these women and it may increase the risk of breast cancer.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - estradiol, quantity: 0.78 mg (equivalent: estradiol, qty 50 microgram/24 h; equivalent: estradiol hemihydrate, qty 0.806 mg) - drug delivery system, transdermal - excipient ingredients: povidone; dipropylene glycol; oleyl alcohol; polyethylene terephthalate; polyvinylidene flouride; ethyl acetate; simethicone; dimeticone; xylene; cyclomethicone; toluene; acrylates/va copolymer; ethylene/vinyl acetate copolymer; 1,1-dichloroethylene, chloroethylene polymer; polyethylene; sodium carbonate - for the short-term treatment of symptoms of oestrogen deficiency in menopausal women who have an intact uterus. combination hrt should not be used in hysterectomised women because it is not needed in these women and it may increase the risk of breast cancer.

European Union - English - EMA (European Medicines Agency)

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyoma - pituitary and hypothalamic hormones and analogues - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - norethisterone acetate; estradiol - oral tablet - 1mg ; 2mg

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - estradiol hemihydrate 0.78mg equivalent to 50 µg/24 hours;  ; estradiol hemihydrate 0.62mg equivalent to 50 µg/24 hours; norethisterone acetate 2.7mg equivalent to 140 µg/24 hours;   - transdermal patch - 50/140 - active: estradiol hemihydrate 0.78mg equivalent to 50 µg/24 hours   excipient: acrylic adhesive dipropylene glycol oleic acid povidone silicone adhesive active: estradiol hemihydrate 0.62mg equivalent to 50 µg/24 hours norethisterone acetate 2.7mg equivalent to 140 µg/24 hours   excipient: acrylic adhesive dipropylene glycol oleic acid povidone silicone adhesive